Ignoring all other facts, hearsay and opinions, it would make zero sense to submit the interview Saturday morning if you wanted to prosper from a false story. This would give the company adequate time to submit a rebuttal before market opens on Monday totally negating any possible stock spike.
If false, wait until 7:15 am Monday to release the story, which would allow a stock spike and a chance to get out before the company scrambles to refute.
This is good news. The tariff stays at 26%. Trina already said it sees robust demand even with tariffs in the US. This gives them a competitive advantage among other Chinese players. Talk about a buy!!
Trading at 76% of book value
As the TOP drug!! This is from the White House Press Release! Notice this is BARDA'S top drug!! Also mentions that it will be developed in tobacco plants. BARDA is supporting Caliber and Caliber = IBIO!!
Excellent news. White house explicitly mentions ZMapp and we all know ZMapp will be produced with IBiolaunch technology from IBIO
Sentiment: Strong Buy
Or more plausible - IBIO knows that it will receive a large contract, which will send the stock to 10. Diluting only 10 million shares and raising cash for OTHER projects - drug trials, which are very expensive but are in multibillion dollar markets. I honestly doubt they think they can dilute $100 million at this share price without sending it down to .1 and the OTC market. They know this! They are prepping themselves to sell into outstanding news of contracts and revenue streams
They have not been selling. Prospectus states: "We may not sell any securities under this prospectus without delivery of the applicable prospectus supplement. "
none sold. and wont be until way higher. Minimal dilution.
WOuld be nice to see some insider buying. would really show some confidence
NVIV too - spinal chord injury repair. They have their first patient with product to help spinal chord injury
The company knows that positive news is on the way with large dollar contracts. More than just ebola, vaccines for everything will license IBiolaunch. Company is set to sell $100 million in stock at much higher prices with minimal dilution. Smart for them to do this NOW instead of spooking the imminent run. The money will only increase shareholder value by allowing them to expand and do drug trials for multi-billion dollar drugs.
Here are my favorite stocks:
IBIO - vaccine production and pipeline
BLRX - incredible pipeline and most unbelievably underpriced stock in history - just needs (AND WILL) to be discovered
DARA- great products - massively underpriced
CANF - great potential and late stage pipeline. Also incredibly underpriced - I do see a secondary coming with this one
Others- non biotech
TSL - best solar play
SIMO - best chip play with divi
TICC, PSEC - business development companies - great divis
Also, BLRX is a TEVA spinoff. CANF and BLRX are those types of stocks that people wonder why they were so low. 3-5 years from now these will both be 10 to even 100x baggers
This filing definitely shows that they are expecting a much higher price. $100 million dollars. notice they did not mention the number of shares like most filings. They are expecting to sell into a large news story is my guess. They are prepping themselves for vaccine BARDA contract news, which will send the stock over 10.
Dilution will be minimal above 10. They certainly are not going to dilute the stock at the current price especially given enough cash on hand through end of next year with revenue coming in from GE plant and others
They have a series of great candidates in various stages including for stem cell mobilization, oncology, celiac disease, infections, heart issues etc. go to Bioline website.
BLRX and CANF - extremely underpriced multiple candidates
IBIO - novel state of the art vaccine play with ebola contract coming soon
NVIV - Spinal chord cure - first patient having encouraging results - making news headlines
Furthermore, BLRX has a much better cash position, partners and low cash burn rate. no need for secondary
I have a law firm more interested in high profile advocacy than making any more money (at least short term). About time this kind of market manipulation stops. there needs to be consequences for lies and slander to make millions by lies
Great people. I just need a list of names and e-mail addresses. Please send to montanafreeride9 at yahoo
Zmapp specifically mentioned. Zmapp will be produced through Caliber = IBIO